MedCity News

FEBRUARY 7, 2025

Bain Capitals buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma appeared first on MedCity News.

Pharma 257

Pharma Pharmaceutical Biopharma 257

PharmaVoice

FEBRUARY 7, 2025

While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.

173

173

MedCity News

FEBRUARY 7, 2025

[Sponsored] A Data-Driven Guide to Patient Access Success highlights how focusing on data accuracy and relevance can enhance healthcare practice performance. The post A Guide to Boosting Healthcare Practice Performance appeared first on MedCity News.

Healthcare 250

Healthcare Healthcare Patients Physicians 250

PharmaVoice

FEBRUARY 7, 2025

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.

Prescription 130

Prescription Sales 130

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

MedCity News

FEBRUARY 7, 2025

Fay’s $50 million Series B round was led by Goldman Sachs. In total, the company has raised $75 million. The post Fay Raises $50M to Expand Access to Nutrition Counseling Services appeared first on MedCity News.

238

238

pharmaphorum

FEBRUARY 7, 2025

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.

FDA 93

FDA 93

Pharmaceutical Technology

FEBRUARY 7, 2025

Sanofi has agreed to purchase its own shares worth 2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

Pharma 98

Pharma 98

pharmaphorum

FEBRUARY 7, 2025

Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.

Pharma 71

Pharma 71

Pharmaceutical Technology

FEBRUARY 7, 2025

With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK charity behind the popular Dry January initiative, found that 30% of men and 26% of women in the UK wished to reduce the amount of alcohol they drank in 2024.

Medical 85

Medical 85

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

PharmaTech

FEBRUARY 7, 2025

In this interview, Pharmaceutical Technology discusses the trend of AI in pharma and how it may play out in 2025 and beyond with Ben Sidders from Biorelate.

Pharma 64

Pharma Pharmaceutical 64

Pharmaceutical Technology

FEBRUARY 7, 2025

Relmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.

Pharma 64

Pharma 64

Pharmacy Times

FEBRUARY 7, 2025

Donna Ryan discusses the landscape of GLP-1 medications and the lineup of indications that the drug class has received indications for in recent years.

Medical 61

Medical 61

PharmaTech

FEBRUARY 7, 2025

Installation was performed during the summer of 2024, and the system has already successfully completed its first production run for a leading biotech company.

Leads 59

Leads 59

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Pharmaceutical Commerce

FEBRUARY 7, 2025

What factors should be consideredand how can both parties benefit long-term?

Pharma 59

Pharma 59

PharmaTech

FEBRUARY 7, 2025

Patient enrollment is currently underway for the highest-dose cohort of AdvanCells potentially best-in-class targeted alpha therapy for metastatic prostate cancer.

Patients 59

Patients 59

Pharmaceutical Technology

FEBRUARY 7, 2025

Alumis and Acelyrin have announced a definitive merger agreement, which will result in an all-stock transaction.

59

59

Pharmacy Times

FEBRUARY 7, 2025

The designation builds on previous regulatory action for ADI-001 and allows for expedited development of the treatment for systemic lupus erythematosus.

FDA 55

FDA 55

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

FEBRUARY 7, 2025

Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.

59

59

Pharmaceutical Commerce

FEBRUARY 7, 2025

From matrix programs to anti-abandonment strategies, predictions for a new era.

Patients 52

Patients 52

Pharmaceutical Technology

FEBRUARY 7, 2025

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to benefit.

Manufacturing 59

Manufacturing Patients 59

PharmExec

FEBRUARY 7, 2025

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.

Management 52

Management Pharmaceutical FDA 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Commerce

FEBRUARY 7, 2025

A cohort study investigates the magnitude of lost coverage among pediatric patients, following the conclusion of the pandemic public health emergency.

Patients 52

Patients 52

PharmExec

FEBRUARY 7, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Commerce

FEBRUARY 7, 2025

Introducing a new Pharma Commerce column focused on combating illicit trade and protecting product integrityand ultimately patients.

Pharma 52

Pharma Patients 52

pharmaphorum

FEBRUARY 7, 2025

MSD has started a phase 3 trial of ROR1-directed ADC zilo-V as a treatment for previously untreated diffuse large B-cell lymphoma.

52

52

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

PharmaTech

FEBRUARY 7, 2025

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

52

52

Pharmaceutical Technology

FEBRUARY 7, 2025

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Healthcare 52

Healthcare Healthcare 52

Pharmaceutical Commerce

FEBRUARY 7, 2025

The latest news for pharma industry insiders.

Pharma 52

Pharma 52